A. L. Elakov

A. L. Elakov

Auto-generated profile, based on publicly available information

A. L. Elakov

ФГБНУ «Федеральный научный центр – Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук» (ФГБНУ ФНЦ ВИЭВ РАН)

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in Problems of Virology
Verified
Journal Article
Open access
PDF file
AEA. L. Elakov
A. L. Elakov
Rabies is almost ubiquitous (except in certain areas) and poses a significant danger to both animals and humans. Every year around 55,000 people die from this disease worldwide. In the Russian Federation alone 400,000– 450,000 patients annually apply for anti-rabies treatment. In the absolute majority of cases human infection is caused by contact with infected animals. In RF, a number of cultured inactivated anti-rabies vaccines for medical and veterinary purposes have been developed, registered and used for specific prevention of rabies. These vaccine preparations have shown high effectiveness in preventing infection in domestic and farm animals. At the same time, the main reservoir of the rabies virus (Mononegavirales: Rhabdoviridae: Lyssavirus) (RV) are wild carnivores (Mammalia: Carnivora). For the purpose of their oral immunization, live virus vaccines from attenuated (fixed) strains of RV that are little resistant in the external environment are used. In Western Europe and North America there is successful experience with recombinant anti-rabies vaccine preparations containing a viral glycoprotein gene (G-protein). Such vaccines are safe for humans and animals. In Russia also had been developed a vector anti-rabies vaccine based on adenovirus (Adenoviridae), which can be used to combat this infection. Currently, in addition to classical rabies, diseases caused by new, previously unknown lyssaviruses (Lyssavirus) are becoming increasingly important. Bats (Mammalia: Microchiroptera) are their vectors. Cases of illness and death after contact with these animals have been described. In the near future, we should expect the development of new vaccines that will provide protection not only against RV, but also against other lyssaviruses.

20 February 2019 in Problems of Virology
Verified
Journal Article
Open access
PDF file
AMArtem Metlin
Artem Metlin
ABA. D. Botvinkin
A. D. Botvinkin
AEA. L. Elakov
A. L. Elakov
KGK. N. Gruzdev
K. N. Gruzdev
Notwithstanding the availability of effective vaccines, 40 - 60 thousand rabies cases in humans are reported every year. Almost always the disease is fatal because therapeutic treatment of lyssavirus encephalitis has not been developed. Since 1970 the number of reports on rare cases of convalescence including those using experimental treatment protocols has been gradually increasing 20 cases of convalescence, “partial” convalescence or long-term survival of humans (1970-2015) were selected as they were complaint with laboratory criteria of active lyssavirus infection. Children and teenagers were predominant in the analyzed group (85%). The cases were irregularly spread between the continents: Asia - 6 cases, North America - 6 cases, Africa - 2 cases and Europe - 1 case. India and the USA were on the top of the list of countries by the number of described cases. More than 60% humans were infected from dogs, three cases got infection from bats and 2 cases were allegedly associated with an unknown lyssavirus and an unidentified infection source. 70% cases were vaccinated and 10% cases were treated with gamma globulin before the disease onset. Serological tests for detection of antibodies to lyssaviruses in cerebrospinal fluid of infected humans were typically used for diagnostic laboratory verification. Less than 30% IFA and PCR positives were obtained. Lyssaviruses were never detected. Only 4 convalescent patients were treated using experimental protocols. 80% cases demonstrated severe neurological consequences, four (may be more) patients died afterwards within the period from two months to four years. Different perspectives on prospects of Milwaukee protocol use and other therapeutic techniques are given.

20 February 2020 in Problems of Virology
Verified
Journal Article
Open access
PDF file
OZO. N. Zaykova
O. N. Zaykova
Tatiana Vladimirovna GrebennikovaTatiana Vladimirovna Grebennikova
Tatiana Vladimirovna Grebennikova
MLM. A. Losich
M. A. Losich
AEA. L. Elakov
A. L. Elakov
AGA. M. Gulyukin
A. M. Gulyukin
AMArtem Metlin
Artem Metlin
Introduction. Rabies caused by the neurotropic virus of the genus Lyssavirus, Rhabdoviridae family, which infects all warm-blooded vertebrates including human beings. The homology level of the amino acid sequences for Lyssaviruses nucleoprotein reaches 78–93%.Aim – study the genetic diversity and molecular epidemiology of Lyssaviruses circulated in the Russian Federation in 1985–2016.Material and methods. 54 isolates of rabies virus isolated from animals, and 2 isolates from humans, 4 vaccine strains of rabies virus: RV-97, ERA, Shchelkovo 51, ERAG333 used in phylogenetic study. Phylogenetic analysis was performed using Genbank data on genome fragments of 73 rabies virus isolates and 9 EBLV-1 isolates. DNASTAR V.3.12, Bio Edit 7.0.4.1 and MEGA v.10.0.5, Primer Premier 5 programs have been used.Results. Comparative molecular genetic analysis of genomes fragments of 130 Lissaviruses, isolated on the territory of the RF, Ukraine in 1985-2016, vaccine strains of rabies virus, showed their distribution by geographical feature. Comparison of the nucleoprotein fragments of the rabies virus isolates with vaccine strains revealed 4 marker mutations: V56I (Eurasian group), L/V95W (Central group), D101N/S/T, and N/G106D. Phylogenetic analysis of the isolate «Juli», isolated from a human bitten by a bat proved his belonging to the European Bat lyssavirus-1a.Discussion. Study of the molecular epidemiology of rabies within the Russian Federation allows for the genotyping of the viruses and helps to study the hidden mechanisms of rabies infection in animal and human populations, and to characterize vaccine strains, including during oral vaccination.Conclusion. Further study of the molecular epidemiology of rabies within the Russian Federation and the countries bordering it is important.

20 March 2014
Verified
Journal Article
Closed access
SGS V Gribencha
S V Gribencha
AKA Iu Kozlov
A Iu Kozlov
LKL V Kostina
L V Kostina
AEA L Elakov
A L Elakov
MLM A Losich
M A Losich
TAT I Aliper
T I Aliper

1 January 2006 in Journal of Environmental Radioactivity
Verified
Journal Article
Closed access
AOAndreyan N. Osipov
Andreyan N. Osipov
VSV.D. Sypin
V.D. Sypin
OPO.G. Polsky
O.G. Polsky
AIA.N. Ilyinov
A.N. Ilyinov
IRI.A. Ryazanov
I.A. Ryazanov
VEV.G. Egorov
V.G. Egorov

1 January 2020 in Immunologiya
Verified
Journal Article
Open access
FFFederal Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation
Federal Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation
MSMaxim Shmarov
Maxim Shmarov
IUI.M. Sechenov First Moscow State Medical University of Ministry of Health of the Russian Federation (Sechenov University)
I.M. Sechenov First Moscow State Medical University of Ministry of Health of the Russian Federation (Sechenov University)
ESE.S. Sedova
E.S. Sedova
ANA.E. Nikonova
A.E. Nikonova
AGA.L. Gintsburg
A.L. Gintsburg